Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’ | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a Reply. Please see:

Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al - April 01, 2023

Correspondence

Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’

Online download statistics by month:

Online download statistics by month: January 2021 to October 2023

	Abstract	Full	Pdf
Jan 2021	208	204	60
Feb 2021	446	430	136
Mar 2021	164	164	42
Apr 2021	66	66	27
May 2021	92	92	18
Jun 2021	48	48	20
Jul 2021	35	36	9
Aug 2021	43	44	12
Sep 2021	31	31	11
Oct 2021	37	34	26
Nov 2021	44	44	23
Dec 2021	102	104	13
Jan 2022	51	51	6
Feb 2022	34	34	11
Mar 2022	34	34	16
Apr 2022	40	41	11
May 2022	35	35	16
Jun 2022	29	29	6
Jul 2022	29	29	6
Aug 2022	32	32	3
Sep 2022	24	24	18
Oct 2022	30	30	7
Nov 2022	29	29	4
Dec 2022	28	28	3
Jan 2023	45	45	8
Feb 2023	30	29	5
Mar 2023	547	16	7
Apr 2023	215	12	8
May 2023	38	1	2
Jun 2023	43	1	1
Jul 2023	29	3	2
Aug 2023	96	1	1
Sep 2023	72	2	1
Oct 2023	100	8	4
Total	2926	1811	543